Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors

We report on liver transplantation in two patients with GSD Ib on treatment with empagliflozin. The use of this SGLT2 inhibitor resulted in a marked decrease of 1,5-anhydroglucitol which has an important role in the development of neutropenia in this condition. As intended, this caused a significant...

Cijeli opis

Bibliografski detalji

Glavni autori:	Simona Murko, Manuela Peschka, Konstantinos Tsiakas, Sebastian Schulz-Jürgensen, Uta Herden, René Santer
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2023-06-01
Serija:	Molecular Genetics and Metabolism Reports
Teme:	Glycogen storage disease Ib GSD1b Liver transplantation SGLT2 inhibitor Empagliflozin
Online pristup:	http://www.sciencedirect.com/science/article/pii/S221442692300023X
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!